Abstract:Multimodal, imaging-genomics techniques offer a platform for understanding genetic influences on brain abnormalities in psychiatric disorders. Such approaches utilize the information available from both imaging and genomics data and identify their association. Particularly for complex disorders such as schizophrenia, the relationship between imaging and genomic features may be better understood by incorporating additional information provided by advanced multimodal modeling. In this study, we propose a novel framework to combine features corresponding to functional magnetic resonance imaging (functional) and single nucleotide polymorphism (SNP) data from 61 schizophrenia (SZ) patients and 87 healthy controls (HC). In particular, the features for the functional and genetic modalities include dynamic (i.e., time-varying) functional network connectivity (dFNC) features and the SNP data, respectively. The dFNC features are estimated from component time-courses, obtained using group independent component analysis (ICA), by computing sliding-window functional network connectivity, and then estimating subject specific states from this dFNC data using a k-means clustering approach. For each subject, both the functional (dFNC states) and SNP data are selected as features for a parallel ICA (pICA) based imaging-genomic framework. This analysis identified a significant association between a SNP component (defined by large clusters of functionally related SNPs statistically correlated with phenotype components) and time-varying or dFNC component (defined by clusters of related connectivity links among distant brain regions distributed across discrete dynamic states, and statistically correlated with genomic components) in schizophrenia. Importantly, the polygenetic risk score (PRS) for SZ (computed as a linearly weighted sum of the genotype profiles with weights derived from the odds ratios of the psychiatric genomics consortium (PGC)) was negatively correlated with the significant dFNC component, which were mostly present within a state that exhibited a lower occupancy rate in individuals with SZ compared with HC, hence identifying a potential dFNC imaging biomarker for schizophrenia. Taken together, the current findings provide preliminary evidence for a link between dFNC measures and genetic risk, suggesting the application of dFNC patterns as biomarkers in imaging genetic association study.

A Framework for Linking Resting-State Chronnectome/genome Features in Schizophrenia: A Pilot Study

Variability in Resting State Network and Functional Network Connectivity Associated with Schizophrenia Genetic Risk: A Pilot Study

Guided Exploration of Genomic Risk for Gray Matter Abnormalities in Schizophrenia Using Parallel Independent Component Analysis with Reference

Associating Multimodal Neuroimaging Abnormalities with the Transcriptome and Neurotransmitter Signatures in Schizophrenia.

Multifaceted genomic risk for brain function in schizophrenia.

Integration of Imaging (epi)genomics Data for the Study of Schizophrenia Using Group Sparse Joint Nonnegative Matrix Factorization

Integration of Multiple Genomic Imaging Data for the Study of Schizophrenia Using Joint Nonnegative Matrix Factorization.

Genome-Transcriptome-Functional Connectivity-Cognition Link Differentiates Schizophrenia from Bipolar Disorder

A Method for Building a Genome-Connectome Bipartite Graph Model.

A Genetically Informed, Group Fmri Connectivity Modeling Approach: Application to Schizophrenia.

A Schizophrenia-Related Genetic-Brain-Cognition Pathway Revealed in a Large Chinese Population.

Multi-modal deep learning from imaging genomic data for schizophrenia classification

Shaping the Trans-Scale Properties of Schizophrenia via Cerebral Alterations on Magnetic Resonance Imaging and Single-Nucleotide Polymorphisms of Coding and Non-Coding Regions

628. Polygenic Risk Score for Schizophrenia of CREB1 and BDNF Associated with Structural Brain Dysconnectivity

Multi-scale Analysis of Schizophrenia Risk Genes, Brain Structure, and Clinical Symptoms Reveals Integrative Clues for Subtyping Schizophrenia Patients

Novel Gene-Brain Structure Relationships in Psychotic Disorder Revealed Using Parallel Independent Component Analyses.

Linked 4-Way Multimodal Brain Differences in Schizophrenia in a Large Chinese Han Population.

Unveiling Promising Neuroimaging Biomarkers for Schizophrenia Through Clinical and Genetic Perspectives

Neuroimaging and Multiomics Reveal Cross-Scale Circuit Abnormalities in Schizophrenia

Brain Function, Structure and Genomic Data Are Linked but Show Different Sensitivity to Duration of Illness and Disease Stage in Schizophrenia

Large-Scale Fusion of Gray Matter and Resting-State Functional MRI Reveals Common and Distinct Biological Markers Across the Psychosis Spectrum in the B-SNIP Cohort